The neuropathological basis for depression in Parkinson's disease

被引:113
作者
Frisina, Pasquale G. [1 ,3 ]
Haroutunian, Vahram [2 ,4 ]
Libow, Leslie S. [1 ,3 ]
机构
[1] Jewish Home & Hosp Life Care Syst, New York, NY 10025 USA
[2] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
[3] Mt Sinai Sch Med, Dept Geriatr & Adult Dev, New York, NY USA
[4] Bronx Vet Adm Hosp, New York, NY USA
关键词
Depression; Parkinson's disease; Clinical-neuropathological; ALZHEIMER-DISEASE; DEMENTIA; DYSFUNCTION; DOPAMINE;
D O I
10.1016/j.parkreldis.2008.04.038
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Depression is found in 30-40% of all patients with Parkinson's disease (PD), but its etiology is unclear. Using neuropathology as a signpost for neurotransmitter function. we investigated the prevalence of pathological features found at postmortem and sought to uncover differences between depressed (n = 11) and non-depressed (n = 9) elderly PD patients. The results indicate a higher prevalence of pathological features in depressed compared to non-depressed PD patients, particularly in catecholamine areas of the brain; the locus coeruleus (neuronal loss: odds ratio = 7.2, p = 08; gliosis: odds ratio = 18.0, p = 008); dorsal vagus nerve (gliosis: odds ratio = 7.63, p < 0.05). and substantia nigra pars compacta (gliosis: odds ratio = 2.85, ns). However, neuropathological differences were absent in the dorsal raphe nuclei, amygdala, and cortical regions. Our evidence suggests that depression in PD is related more to catecholaminergic than serotonergic system dysfunction. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:144 / 148
页数:5
相关论文
共 34 条
[1]  
ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119
[2]  
ANDERSEN J, 1980, ACTA NEUROL SCAND, V62, P210
[3]   Stages in the development of Parkinson's disease-related pathology [J].
Braak, H ;
Ghebremedhin, E ;
Rüb, U ;
Bratzke, H ;
Del Tredici, K .
CELL AND TISSUE RESEARCH, 2004, 318 (01) :121-134
[4]  
Braak H., 2002, J Neurol, V249, DOI DOI 10.1007/S00415-002-1301-4
[5]   Assessment of Parkinson's disease with imaging [J].
Brooks, David J. .
PARKINSONISM & RELATED DISORDERS, 2007, 13 :S268-S275
[6]   Psychopharmacology [J].
Cameron, OG .
PSYCHOSOMATIC MEDICINE, 1999, 61 (05) :585-590
[8]   Tremor in Parkinson's disease and serotonergic dysfunction -: An 11C-WAY 100635 PET study [J].
Doder, M ;
Rabiner, EA ;
Turjanski, N ;
Lees, AJ ;
Brooks, DJ .
NEUROLOGY, 2003, 60 (04) :601-605
[9]   Effect of vagus nerve stimulation on serotonergic and noradrenergic transmission [J].
Dorr, Adrienne E. ;
Debonnel, Guy .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (02) :890-898
[10]   Depression and Parkinson's disease: A new look at an old problem [J].
Edwards, E ;
Kitt, C ;
Oliver, E ;
Finkelstein, J ;
Wagster, M ;
McDonald, WM .
DEPRESSION AND ANXIETY, 2002, 16 (01) :39-48